
Paul Chang Lee
Examiner (ID: 11644, Phone: (571)270-7923 , Office: P/2871 )
| Most Active Art Unit | 2871 |
| Art Unit(s) | 2883, 2871 |
| Total Applications | 1108 |
| Issued Applications | 832 |
| Pending Applications | 72 |
| Abandoned Applications | 220 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7429824
[patent_doc_number] => 20040001851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Polyvalent immunogen'
[patent_app_type] => new
[patent_app_number] => 10/373592
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10982
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001851.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373592 | Polyvalent immunogen | Feb 25, 2003 | Issued |
Array
(
[id] => 6673800
[patent_doc_number] => 20030059403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Phaseolamin compositions and methods for using the same'
[patent_app_type] => new
[patent_app_number] => 10/233643
[patent_app_country] => US
[patent_app_date] => 2002-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4874
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10233643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/233643 | Phaseolamin compositions and methods for using the same | Sep 2, 2002 | Issued |
Array
(
[id] => 6813272
[patent_doc_number] => 20030072822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Methods for treating disorders using plant extracts'
[patent_app_type] => new
[patent_app_number] => 10/232756
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14236
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072822.pdf
[firstpage_image] =>[orig_patent_app_number] => 10232756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/232756 | Method for treating type 2 diabetes with an extract of Artemisia | Aug 29, 2002 | Issued |
Array
(
[id] => 7357669
[patent_doc_number] => 20040014030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Enzymatic assay of HIV protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/200096
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5330
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200096
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200096 | Enzymatic assay of HIV protease inhibitors | Jul 17, 2002 | Abandoned |
Array
(
[id] => 6851045
[patent_doc_number] => 20030143248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/190435
[patent_app_country] => US
[patent_app_date] => 2002-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 157
[patent_figures_cnt] => 157
[patent_no_of_words] => 46031
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190435 | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof | Jul 4, 2002 | Issued |
Array
(
[id] => 612943
[patent_doc_number] => 07148341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'AAV DNA comprising helper virus sequences'
[patent_app_type] => utility
[patent_app_number] => 09/923270
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2006
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148341.pdf
[firstpage_image] =>[orig_patent_app_number] => 09923270
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/923270 | AAV DNA comprising helper virus sequences | Aug 2, 2001 | Issued |
Array
(
[id] => 5889563
[patent_doc_number] => 20020013453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Antibodies specific for proteins having polyglutamine expansions'
[patent_app_type] => new
[patent_app_number] => 09/922483
[patent_app_country] => US
[patent_app_date] => 2001-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6626
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013453.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922483
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922483 | Antibodies specific for proteins having polyglutamine expansions | Aug 1, 2001 | Abandoned |
Array
(
[id] => 507860
[patent_doc_number] => 07195765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-27
[patent_title] => 'Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents'
[patent_app_type] => utility
[patent_app_number] => 09/899046
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 111
[patent_figures_cnt] => 13
[patent_no_of_words] => 28141
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/195/07195765.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899046
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899046 | Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents | Jul 5, 2001 | Issued |
Array
(
[id] => 1017673
[patent_doc_number] => 06890565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-10
[patent_title] => 'Process for preparing coagulants for water treatment'
[patent_app_type] => utility
[patent_app_number] => 10/149385
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1689
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/890/06890565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10149385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/149385 | Process for preparing coagulants for water treatment | Apr 1, 2001 | Issued |
Array
(
[id] => 6801203
[patent_doc_number] => 20030096368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Isolated FrpB nucleic acid molecule and vaccine'
[patent_app_type] => new
[patent_app_number] => 09/801451
[patent_app_country] => US
[patent_app_date] => 2001-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10509
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096368.pdf
[firstpage_image] =>[orig_patent_app_number] => 09801451
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/801451 | Isolated FrpB nucleic acid molecule and vaccine | Mar 7, 2001 | Abandoned |
Array
(
[id] => 6616991
[patent_doc_number] => 20020064838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS'
[patent_app_type] => new
[patent_app_number] => 09/766344
[patent_app_country] => US
[patent_app_date] => 2001-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 44786
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064838.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766344
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766344 | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Jan 18, 2001 | Issued |
Array
(
[id] => 6274740
[patent_doc_number] => 20020106375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Non-cytolytic soluble factor from activated-expanded CD4 cells'
[patent_app_type] => new
[patent_app_number] => 09/727198
[patent_app_country] => US
[patent_app_date] => 2000-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 26929
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106375.pdf
[firstpage_image] =>[orig_patent_app_number] => 09727198
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/727198 | Non-cytolytic soluble factor from activated-expanded CD4 cells | Nov 29, 2000 | Abandoned |
Array
(
[id] => 1043439
[patent_doc_number] => 06866872
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-15
[patent_title] => 'Withania somnifera Dunal extracts for increasing male sperm count'
[patent_app_type] => utility
[patent_app_number] => 10/031650
[patent_app_country] => US
[patent_app_date] => 2000-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3105
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/866/06866872.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031650
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031650 | Withania somnifera Dunal extracts for increasing male sperm count | May 8, 2000 | Issued |
Array
(
[id] => 7607407
[patent_doc_number] => 07098309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'Recombinant hepatitis B surface antigen'
[patent_app_type] => utility
[patent_app_number] => 09/469485
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 9607
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098309.pdf
[firstpage_image] =>[orig_patent_app_number] => 09469485
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469485 | Recombinant hepatitis B surface antigen | Dec 21, 1999 | Issued |
Array
(
[id] => 4194956
[patent_doc_number] => 06130365
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-10
[patent_title] => 'Breeding lines of color-sexable day-old chicks and methods for producing the same'
[patent_app_type] => 1
[patent_app_number] => 9/422190
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7210
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/130/06130365.pdf
[firstpage_image] =>[orig_patent_app_number] => 422190
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/422190 | Breeding lines of color-sexable day-old chicks and methods for producing the same | Oct 21, 1999 | Issued |
Array
(
[id] => 606224
[patent_doc_number] => 07153589
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-12-26
[patent_title] => 'Mo-W material for formation of wiring, Mo-W target and method for production thereof, and Mo-W wiring thin film'
[patent_app_type] => utility
[patent_app_number] => 09/165743
[patent_app_country] => US
[patent_app_date] => 1998-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 11092
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153589.pdf
[firstpage_image] =>[orig_patent_app_number] => 09165743
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/165743 | Mo-W material for formation of wiring, Mo-W target and method for production thereof, and Mo-W wiring thin film | Oct 5, 1998 | Issued |
| 09/127899 | BREEDING LINES OF COLOR-SEXABLE DAY-OLD CHICKS AND METHODS FOR PRODUCING THE SAME | Aug 2, 1998 | Abandoned |
Array
(
[id] => 4157597
[patent_doc_number] => 06156736
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Gene transcription and ionizing radiation: methods and compositions'
[patent_app_type] => 1
[patent_app_number] => 9/102997
[patent_app_country] => US
[patent_app_date] => 1998-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 31218
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156736.pdf
[firstpage_image] =>[orig_patent_app_number] => 102997
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/102997 | Gene transcription and ionizing radiation: methods and compositions | Jun 21, 1998 | Issued |
Array
(
[id] => 4190180
[patent_doc_number] => 06153598
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Synthetic transfection vectors'
[patent_app_type] => 1
[patent_app_number] => 9/062145
[patent_app_country] => US
[patent_app_date] => 1998-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4107
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153598.pdf
[firstpage_image] =>[orig_patent_app_number] => 062145
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/062145 | Synthetic transfection vectors | Apr 16, 1998 | Issued |
Array
(
[id] => 4151164
[patent_doc_number] => 06124119
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-26
[patent_title] => 'mecB'
[patent_app_type] => 1
[patent_app_number] => 9/040843
[patent_app_country] => US
[patent_app_date] => 1998-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15703
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/124/06124119.pdf
[firstpage_image] =>[orig_patent_app_number] => 040843
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/040843 | mecB | Mar 17, 1998 | Issued |